F.D.A. Says Pfizer Vaccine’s Benefits Outweigh Key Risks in Children 5 to 11
WASHINGTON — Federal regulators evaluated for the first time on Friday the safety and efficacy of a coronavirus vaccine for children 5 to 11, saying that the benefits of staving off Covid-19 with the Pfizer-BioNTech vaccine generally outweighed the risks of the most worrisome possible side effects in that age group. The analysis came on…
Details